Navigation Links
INNOPHARMA Receives First FDA Approval
Date:2/2/2010

MONMOUTH JUNCTION, N.J., Feb. 2 /PRNewswire/ -- INNOPHARMA LLC announced today FDA approval of the Abbreviated New Drug Application (ANDA) for ibutilide fumarate injection (the generic equivalent of Corvert® from Pfizer Inc).

As the developer of this generic injectable drug, INNOPHARMA entered into a license agreement with Bioniche Pharma USA for marketing and product distribution of the injection product. Ibutilide fumarate injection represents INNOPHARMA's first approved drug in their product pipeline.

Please refer to the Bioniche Pharma website to be directed to the complete prescribing information for this product, including the boxed warning.

About INNOPHARMA:

INNOPHARMA is a research and development company, focused on developing niche generic and specialty pharmaceutical products.  Through a business model of internal product development and commercialization licensure, INNOPHARMA has a comprehensive infrastructure for development of parenteral pharmaceutical products at its New Jersey facilities.  INNOPHARMA works with manufacturing and clinical research organizations worldwide for commercialization of its developed products.  More information about INNOPHARMA can be found at www.innopharmallc.com.  

About Bioniche Pharma:

Bioniche Pharma is a global manufacturer of injectable pharmaceutical products serving a variety of niche markets, including anesthesiology, orthopedics, rheumatology, urology, and dermatology. An internal development pipeline and an aggressive acquisition strategy for products fue
'/>"/>

SOURCE INNOPHARMA LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
2. Mylan Receives Approval for Generic Version of GoLytely(R)
3. Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatment
4. Notal Visions ForeseeHome(TM) AMD Monitor Receives FDA Clearance
5. Medicsight PLC Receives Additional Information Request for FDA 510(k) Clearance
6. Novo Nordisks Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
7. KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director
8. Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R) - A Replacement Therapy Developed Specifically for von Willebrand Disease
9. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Ofloxacin and Fleroxacin
10. GeneGo Receives SBIR Grant
11. WorldHeart Receives Unconditional BTT Study Approval From FDA for Levacor(TM) VAD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 20, 2014  RedRick Technologies, ... solutions and reading room environment guidance, has helped ... musculoskeletal radiology reading room, which may also serve ... at Penn Medicine. "In line ... American College of Radiology,s Imaging 3.0 ™ ...
(Date:11/21/2014)... Depomed, Inc. (NASDAQ: DEPO ) today announced ... Annual Healthcare Conference in New York City ... scheduled for 8:00 am EST (5:00 am PST) on Tuesday December ... be accessed via the Investor Relations page of the Depomed website ... archived for 30 days on the company,s website. ...
(Date:11/21/2014)... Texas , Nov. 21, 2014  Lexicon Pharmaceuticals, ... pricing of its previously announced underwritten public offering of ... an effective shelf registration statement. The offering will consist ... offering price of $1.005 per share.  Lexicon has also ... to 7,462,687 additional shares of common stock.  All of ...
Breaking Medicine Technology:RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 3Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2Lexicon Announces Pricing Of Common Stock Offering 2Lexicon Announces Pricing Of Common Stock Offering 3
... BRISTOL, Tenn., May 22, 2007,/PRNewswire-FirstCall/ -- Palatin ... that data from Study 16 and,Study 17 ... evaluating,bremelanotide in men with erectile dysfunction (ED) ... (AUA) Annual,Meeting (AUA 2007) held in Anaheim, ...
... Abuse-Related Effects For OROS(r),Methylphenidate , Two New ... , SAN DIEGO, CA, May 22, 2007 ... for parents and physicians who prescribe,medications to ... on Tuesday at the 160th Annual Meeting ...
Cached Medicine Technology:Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 2Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 3Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 4Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 5Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 6Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 7New Data Focuses on Abuse of Stimulant Medication 2New Data Focuses on Abuse of Stimulant Medication 3New Data Focuses on Abuse of Stimulant Medication 4New Data Focuses on Abuse of Stimulant Medication 5
(Date:11/23/2014)... Wright & Schulte LLC recently filed ... West Virginia residents who allege that they developed thyroid ... to drinking C8 contaminated water released by the ... to the C8 complaints, the plaintiffs were exposed to ... in at least one of the six water districts ...
(Date:11/23/2014)... City, Utah (PRWEB) November 23, 2014 ... health insurance reimbursement for small businesses, announced their ... book, The End of Employer-Provided Health Insurance. ... insurance is the greatest financial risk facing most ... facing U.S. employers, small and large, when it ...
(Date:11/22/2014)... 23, 2014 A new AlignLife Chiropractic ... in the downtown Greenville area. Dr. Chelsea Sineath, owner ... decided to open her own clinic after working in ... the patients. , AlignLife believes that the body ... a focus on chiropractic care and rehabilitation to allow ...
(Date:11/22/2014)... PrettyTailor , an outstanding dress company, has recently ... can buy new dresses at its online shop now. ... , As a matter of fact, PrettyTailor specializes in ... four types of wedding outfits, including bridesmaid dresses, mother ... also provides a variety of occasion dresses, such as ...
(Date:11/22/2014)... A classic black prom dress will never ... dress suppliers, has unveiled its new items of black ... offered at a big discount, up to 70% off. People ... The new black prom dresses, made with the best materials, ... needs of all customers, the company provides these beautiful outfits ...
Breaking Medicine News(10 mins):Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 2Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 3Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 4Health News:Zane Benefits, Inc. Announces New Webinar on The End of Employer-Provided Health Insurance Now Available On-Demand! 2Health News:AlignLife of Downtown Greenville is Now Open and Accepting New Patients 2Health News:Customers Are Welcome to Shop at PrettyTailor.com 2Health News:New Black Prom Dresses from BellasDress.com 2
... Achieve ... Medical and Dental Education, FORT KNOX, Ky., ... a new $20,000 Critical Skills Accession Bonus (CSAB),incentive for medical ... Hebert Armed Forces Health Professions Scholarship Program,(HPSP)., The Health ...
... Beaumont Technology,Usability Center will begin research on the ... study on tubing and catheter misconnection errors., ... Event Alert on the,potential dangers of tubing misconnections. ... of permanent loss of function were due to ...
... mineral supplements among cancer survivors is widespread, despite inconclusive ... comprehensive review of scientific literature conducted by researchers at ... in the Journal of Clinical Oncology. , Can vitamin ... treatment, decrease the risk of cancer recurrence or improve ...
... Black Rat (Rattus rattus) has shed light on the ... globe. , Studying the mitochondrial DNA of 165 Black ... international team of scientists has identified six distinct lineages ... a different part of Asia. , Black Rats are ...
... Efficacy of Acne ... ... Shamban, MD and co-investigators Mikiko,Enokibori, MD, and Vic Narurkar, MD, conducted ... degrees of acne,ranging from mild and moderate inflammatory acne to severe ...
... NORCROSS, Ga., Feb. 1 MediPurpose, an innovator in ... for its industry-,leading SurgiLance safety lancet. In recognition of ... on Thursday, Feb. 21, at,the offices of MMS Medical ... millionth lancet., "We want all our customers to ...
Cached Medicine News:Health News:Army Offers New $20,000 Signing Bonus for Medical and Dental School Scholarship Recipients 2Health News:Army Offers New $20,000 Signing Bonus for Medical and Dental School Scholarship Recipients 3Health News:FDA Renews its Contract with Beaumont Technology Usability Center for Leadership of Patient Safety Project 2Health News:Study finds widespread vitamin and mineral use among cancer survivors 2Health News:Globetrotting black rat genes reveal spread of humans and diseases 2Health News:New Study Shows Isolaz Can Reduce Acne Up to 90 Percent 2Health News:New Study Shows Isolaz Can Reduce Acne Up to 90 Percent 3Health News:MediPurpose Sells 500 Millionth Safety Lancet to IMCO Member MMS Medical 2
Used after ablation to wash away particulate from anterior & posterior sides of flap & stromal bed. Conforms to the corneal flap. .0mm extension with a 11.0mm radius, Angled tip....
Smaller diameter wire probes & olive shape tips provide easier insertion through the lacrimal sac, 35cm (14 in) long, ID- .30mm (.012in); OD- .64mm (.025 in). S.S. Probes: .40mm x 11cm (27 G x 4 1/4...
...
...
Medicine Products: